Cornell Pochily Investment Advisors, Inc. Gilead Sciences, Inc. Transaction History
Cornell Pochily Investment Advisors, Inc.
- $286 Million
- Q3 2024
A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 10,594 shares of GILD stock, worth $980,686. This represents 0.31% of its overall portfolio holdings.
Number of Shares
10,594
Previous 11,031
3.96%
Holding current value
$980,686
Previous $756,000
17.33%
% of portfolio
0.31%
Previous 0.29%
Shares
27 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
992MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.7 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.09 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.72 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.57 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $116B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...